Mobidiag Oy, a pioneering company in the field of molecular diagnostics, is headquartered in Finland (FI) and operates extensively across Europe and beyond. Founded in 2009, Mobidiag has established itself as a leader in the development of innovative diagnostic solutions, particularly in the areas of infectious diseases and antibiotic resistance. The company’s core offerings include the Novodiag® and Amplidiag® product lines, which are distinguished by their rapid, accurate testing capabilities. These products leverage cutting-edge technology to provide healthcare professionals with timely and reliable results, enhancing patient care and treatment outcomes. With a strong commitment to research and development, Mobidiag has achieved significant milestones, positioning itself as a trusted partner in the diagnostics industry. Its unique approach to molecular testing has garnered recognition, making it a key player in the global market for diagnostic solutions.
We don't have data for Mobidiag Oy, but we can show you information about their parent organization instead.
View parent company